Registry Study of Ventricular Tachycardia in Adults with Structural Heart Disease Observing Treatments and Long-Term Outcomes Across Multiple Centers in China

What this Trial Is About

Ventricular tachycardia related to structural heart disease SHD-VT causes significant health problems and risk of death. This nationwide, multicenter, prospective observational registry in China aims to collect detailed information on about 1,000 adult patients with SHD-VT to understand their characteristics, treatment patterns, outcomes, and factors affecting prognosis. The study does not change patient care but collects real-world data to improve clinical decisions and future research. Participants will receive their usual clinical care as determined by their doctors, which may include antiarrhythmic drugs, catheter ablation, implantable cardioverter-defibrillator ICD implantation, cardiac resynchronization therapy with defibrillator CRT-D, surgery, or other treatments as needed. The study records all treatments and follows patients without influencing therapy choices. Enrollment includes adults with documented sustained or clinically significant nonsustained ventricular tachycardia alongside structural heart disease. During the study, researchers will collect demographic, medical history, imaging, lab, and electrophysiological data as well as treatment details and follow-up outcomes. Participants will be monitored for at least 12 months to assess recurrence of ventricular tachycardia, ICD therapies, hospitalizations, and survival. Additional measures include quality of life, patient-reported outcomes, and safety events. This long-term registry aims to provide valuable evidence on managing SHD-VT patients.

Ventricular Tachycardia：A Registry Study